Larner College of Medicine

Membership Benefits

UVM Cancer Center membership comes with many benefits. 

These incentives support emerging research, foster collaboration across the cancer center, and increase access to shared resources. 

Grant Resources

Grant Incentive Programs

Body

Eligible investigators with an R01-equivalent, cancer relevant, peer-reviewed grant will be eligible for $10,000 to be utilized to support research activities.  Awards will be distributed at the start of each fiscal year.  Funds may not be used for PI salary support.

Grant Incentive Program #1: R01 program – Eligible investigators with an R01-equivalent, cancer relevant, peer-reviewed grant will be eligible for $10,000 to be utilized to support research activities.  Awards will be distributed at the start of each fiscal year.  Funds may not be used for PI salary support.

Grant Incentive Program #2: NCI program – Investigators who obtain a new award from the NCI will be eligible for $5,000 to be utilized to support research activities.  Funds may not be used for PI salary support.  Competitive renewals will count as new awards.  Annual renewals, NCE and subcontracts excluded (unless investigator is listed as multiple PI (MPI) for the overall award).

More details about our grant incentive programs (PDF)

Grant Accelerator Program

Body

Grant Accelerator Program - Members who have received a score of 25th percentile or better for a cancer focused grant that was not funded, will be awarded $50,000 to support research to enable resubmission of an “A1” proposal. 

More details about our grant accelerator program (PDF)

Grant Resources

Body
  • Up to a $500 honorarium for outside review of NIH, DOD, or other peer-reviewed grants priors to submission.
  • Grant writer support for NIH/DOD submissions
  • Manuscript editing support

Grant Review

Body

The Cancer Center provides a range of review options to support investigators at various stages of grant development. These options can be used independently or in combination, depending on the specific needs of the proposal. 

Investigators may submit their specific aims or full grant file and select the type(s) of review most appropriate for their current stage. Each review is intended to offer constructive feedback to help improve the quality and clarity of the application.

Quick Peer/Expert Early Critique (PEEC)

Purpose: Early-stage expert feedback
Process: Investigators at any level may submit a draft of their abstract or specific aims page for review. It will be referred to a qualified subject matter expert for appropriate feedback.

Timeline: To maximize benefit, abstracts or aims should be submitted at least 3-4 months in advance of the grant due date. 


Start a Review

Research Community Advisory Board (Research CAB)

Purpose: Evaluate broader community relevance and impact
Process: Before finalizing the grant for external review, investigators may request feedback from the Research CAB. This group includes community stakeholders and researchers who have diverse perspectives on the potential community impact of the project.

Start a Review

Research CAB Members:

Jim Wallace, MD 
Radiation Oncologist  
Former Medical Director, Radiation Oncology 

Mark Levine, MD 
Former Vermont Health Commissioner

Terri Messier 
Former Research Analyst 
University of Vermont

Andrea Villanti PhD, MPH 
Former Associate Professor, Psychiatry and Psychological Sciences 
University of Vermont

Barbara Grant, MD 
Associate Professor Emeritus, Hematology 
University of Vermont

External Reviewer Evaluation

Purpose: Expert, in-depth final review
Process: The Cancer Center coordinates and funds an external review by a qualified expert. This adds a final layer of rigor to ensure the application is competitive for submission.

Ready to Submit?
Contact CRTEC at crtec@med.uvm.edu.

Shared Resources and Cancer Crypto Currency

Body
  • Cancer Center support of Biostatistics SR facilitates access for Cancer Center members for protocol and grant development
  • Availability of Clinical Trials Office for clinical trials support and management
  • For full and associate members: "Cancer Crypto Currency"
    • $10,000 annually from the UVM Cancer Center to pay for services from shared resources: genomics, microscopy, flow cytometry, proteomics, organoid
    • Crypto currency can be used for a single shared resource or across multiple shared resources

More information about shared resources.

High Impact Publication Initiative (HIPI)

Body

Publication in a journal with an impact factor ≥ 10:

  • Cancer Center provides up to $2,000 to:
    • Cover publication costs
    • Cover travel costs for the PI or co-author to attend scientific meeting
  • Members can utilize this program up to 2 times per calendar year
  • Must be utilized within 12 months of the publication date

Pilot Awards

Body
  • Opportunity to compete for Cancer Center seed (pilot) grant awards
  • Opportunity to compete for career development grants (e.g. Clinical Investigator Development Initiative) 

More information about intramural funding opportunities.

Conferences, Research, and Visiting Faculty

Body

Cancer Center events (retreats, seminars, invited lectures, etc)UVM Cancer Center Seminar Series

Program meetings and learning opportunitiesProgram meeting Schedule

Program leaders have an annual budget to cover travel and honorarium

Communications Support

Body
  • Support with public dissemination of research findings
  • Profile hosted on the UVM Cancer Center membership directory
  • Media training and consultation

View membership directory

View UVM Cancer Center News

Clinical Research & Investigator Funding Support

Body

Clinical Investigator Benefits

Clinical Investigator Development Initiative (CIDI) - The UVMCC will provide support up to 25% effort for 2 years (at NIH cap) to facilitate productivity and career development as clinician investigators. Successful candidates are expected to develop and activate a minimum of one investigator-initiated interventional clinical trial during each year of support.

Clinical Investigator-Initiated Therapeutic Trial Opportunity (CIITTO) - The UVMCC will provide support of 20% effort for 1 year to facilitate productivity and career development as a clinician investigator. Successful candidates are expected to develop and activate a minimum of two investigator-initiated therapeutic clinical trials during the period of support.

Investigator-Initiated Therapeutic Trial Incentive (IITTI) - The UVMCC will provide support of $15,000 for therapeutic trial proposals to support regulatory, data management and clinical research coordination through the UVMCC Clinical Trials Office.

Master Trialist Program - The UVMCC will provide 10% salary support for individuals to serve as Master Trialists for the Cancer Center for up to two years.

More details about our Clinical Investigator Development Initiative (PDF)

More details about our Clinical Investigator-Initiated Therapeutic Trial Opportunity (PDF)

More details about our Investigator-Initiated Therapeutic Trial Incentive (PDF)

More details about our Master Trialist Program (PDF)

Clinical Research Benefits

Underfunded Clinical Trial Award - Limited funds are available each year to support high priority, underfunded clinical trials

More details about our underfunded clinical trial awards (PDF)

More Membership Resources

Questions? 

Please contact Kate Webster, Executive Director of Administration at Kate.Webster@med.uvm.edu.